Cartography

Cartography Biosciences is a precision immunotherapy company developing the next-generation of targeted cancer therapies. Cartography is creating the first antigen atlas to identify targets that are specific to cancer, through comprehensive profiling of both healthy and tumor tissues, and using these insights to develop a pipeline of immunotherapies that are both safer and more effective.  They are bridging immunology, genomics, and computational biology to understand the subtle, critical differences between normal and cancerous cells, ultimately solving the challenge of identifying targets for currently untreatable cancers.